Healthcare Services Group heads into its third-quarter report with a story that sounds better than its stock chart. Management spent the last call projecting confidence, pointing to a recovered nursing home workforce, a fuller acquisition pipeline and a deregulatory backdrop. Yet the shares have fallen about 14% since that report, trailing the S&P 500 by more than 18 percentage points. That gap suggests the market doubts whether the upbeat narrative can survive two pressures at once: a full-year plan that leans heavily on the back half, and margins that were flattered by one-time benefits now running out.

The Street expects earnings of $0.22 a share on revenue of about $479.9 million. That revenue figure sits squarely at the midpoint of management's $475 million to $485 million third-quarter target, which itself was a step up from the prior two quarterly ranges. Revenue growth of roughly 3.4% from the year-ago $464.3 million would be modest but consistent with the mid-single-digit trajectory management reaffirmed. The earnings picture is less flattering. Consensus implies a 4.4% decline from last year's $0.23 and a sharp sequential drop from the $0.32 posted last quarter, which tells you analysts have already baked in a meaningful margin reset.

That reset is the crux of the quarter. The actuarial benefit from workers' compensation and general liability reserves shrank to $1.3 million last quarter from more than $4.5 million in the first quarter, and management signaled it is heading toward zero. Cost of services rose to 84.1% of revenue from 83.6%, still below the company's 86% target but clearly drifting upward. A print that holds cost of services well under the target without insurance help would suggest the underlying operations are stronger than the Street assumes. A jump toward or past 86% would confirm that recent profitability was borrowed from one-offs. Food inflation is a secondary watch item: the food-at-home index ticked up for the first time after three consecutive declines, and while contracts allow cost pass-through, timing lags can pinch the dining segment.

Bad debt deserves equal attention. Provisions ran below 1% of revenue for two straight quarters, well under the historical 1% to 1.5% band, and management framed this as a structural gain from tighter contracts and collections. Another sub-1% quarter would support that claim and help offset fading insurance credits. A rebound would undercut one of the more durable-looking pillars of the margin story.

On the growth side, the key question is whether new business is actually starting. Management attributed the back-half weighting to timing rather than to committed start dates, which leaves room for slippage. Revenue landing near or above the guided midpoint, along with a fourth-quarter outlook that keeps the annual plan intact, would validate that explanation. Updates on the Genesis sale, which management expected to close late in the third quarter or early in the fourth, and on deal activity following the April campus acquisition will also matter, particularly since an aggressive buyback pace has left limited room on the current authorization and competes with acquisitions for capital.

Sentiment has cooled noticeably, with bullish readings falling from 48.3% before the last report to 28.0% now. The stock trades at $20.63, below its 200-day moving average of $21.13 and only about 2% above its post-earnings low of $20.17. Expectations, in other words, are subdued. The central issue is whether revenue can hit the stepped-up guide while margins normalize gracefully. If the top line delivers and core costs hold, the pessimism looks overdone; if the ramp slips just as the cushions disappear, the confident tone from last quarter will be hard to defend.